First Patient Enrolled in Phase 3 Clinical Trial Evaluating ARINA-1 in Lung Transplant
Source | Business Wire April 18, 2023 08:52 AM Eastern Daylight Time CHAPEL HILL, N.C - Renovion, Inc. today announced that the first...
In our target diseases, thick mucus often accumulates in the lungs and cannot be effectively cleared out of the airways, which leads to mucus plugging and difficulty breathing.